glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
Published January 22, 2025 · Recall initiated: December 17, 2024
Summary
FDA records drug Class II recall D-0202-2025, published January 22, 2025 and initiated December 17, 2024. Recalling firm: Amerisource Health Services LLC; Status: Terminated; Reported quantity: 2,028 units (cartons of 30 individual unit doses); Lot: Lot # 1012910, Exp Date: 04/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications:
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Amerisource Health Services LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot # 1012910, Exp Date: 04/30/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrimidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by:May 27, 2026
- FDAPrimidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by:May 27, 2026
- FDAMeclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mgApril 1, 2026
- FDAOxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, TheFebruary 18, 2026
- FDAClobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, AmnealJanuary 22, 2025
- FDACardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
Questions about this recall
Was glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11 recalled?
Yes. FDA published recall D-0202-2025 on January 22, 2025. Reported hazard: Failed Dissolution Specifications:
What should I do if I have this product?
Voluntary: Firm initiated · Letter